New hope for leukemia patients Who've run out of options
Disease control
Terminated
This study tested whether an experimental drug called DFP-10917 could help adults with acute myeloid leukemia (AML) whose cancer has returned or stopped responding after multiple previous treatments. Researchers compared DFP-10917, given through continuous IV infusion, against va…
Phase: PHASE3 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC